THE FUND FOR BLOOD AND CANCER RESEARCHINC

EIN: 133064424 501(c)(3)

BETHESDA, MD

Total Revenue
$59,433
Total Expenses
$283,350
Total Assets
$2,026,458
Net Assets
$2,026,458
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1980
Legal Domicile
NY
Principal Officer
DR MARK PASMANTIER
Phone
2125175900
Tax Period
2023-01-01 to 2023-12-31

THE FUND FOR BLOOD AND CANCER RESEARCHINC, founded in 1980, is a micro nonprofit that reported $59K in total revenue in fiscal year 2023. Revenue fell 40% from the prior year — a significant decline worth monitoring. Expenses of $283K exceeded revenue, resulting in a 377% operating deficit.

Mission

CANCER RESEARCH

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $14,512
Program Service Revenue $0
Investment Income $44,921
Other Revenue $0
TOTAL REVENUE $59,433

Expense Breakdown

Grants Paid $257,482
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $262,616
Other Expenses $25,868
TOTAL EXPENSES $283,350

Year-over-Year Comparison

2023 2022 Change
Revenue $59,433 $99,757 -0.4%
Expenses $283,350 $47,586 +5.0%
Net Income $-223,917 $52,171 -5.3%
Key Indicators
✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
2
Independent Members
2
Employees
N/A
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$0
Total Directors
2
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
MORTON COLEMAN MD CO-CHAIRMAN 5.00
Officer Director
$0 $0 $0
MARK PASMANTIER MD CO-CHAIRMAN 5.00
Officer Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $59,433 $283,350 $2,026,458 $-223,917
2022 $99,757 $47,586 $2,128,056 $52,171
2021 $112,918 $35,191 $2,305,853 $77,727
2020 $83,256 $36,706 $2,162,190 $46,550
Explore More Nonprofits
→Top 100 Nonprofits in Maryland →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare THE FUND FOR BLOOD AND CANCER RESEARCHINC with other nonprofits in Maryland and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.